Activators of Lipocalin-12 function through various biochemical mechanisms to enhance its activity within the cell. Some of these activators work by increasing intracellular levels of cyclic adenosine monophosphate (cAMP), a secondary messenger that plays a crucial role in cell signaling. The elevation of cAMP is achieved through different means, such as direct activation of adenylate cyclase, which catalyzes the conversion of ATP to cAMP, or by inhibition of phosphodiesterases, which normally break down cAMP into inactive molecules. The increased cAMP activates protein kinase A (PKA), which phosphorylates target proteins and may influence the functional activity of Lipocalin-12 by altering its interaction with other cellular components or its localization within the cell.
Other activators influence Lipocalin-12 through modulation of intracellular calcium levels. Calcium ionophores directly increase calcium ion concentration within the cytosol, activating calcium-dependent signaling pathways. These pathways often involve calcium-sensitive proteins and enzymes that could play a role in the regulation of Lipocalin-12 activity. Additionally, compounds that act as agonists at calcium channels or influence cellular ion pumps alter the ionic balance, leading to secondary effects on calcium signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As an activator of protein kinase C (PKC), PMA can modulate signaling pathways that influence the activity of Lipocalin-12. PKC activation can result in altered cellular processes that increase the functional activity of Lipocalin-12. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
This calcium ionophore raises intracellular calcium levels, which can activate calcium-dependent signaling pathways, potentially leading to the functional activation of Lipocalin-12 through calcium-mediated signaling events. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
By increasing intracellular calcium concentration, A23187 can indirectly activate Lipocalin-12 by stimulating calcium-sensitive proteins and enzymes that modulate Lipocalin-12 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A β-adrenergic agonist that elevates cAMP levels, leading to the activation of PKA. PKA may then phosphorylate proteins that regulate Lipocalin-12 activity, ultimately increasing its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A phosphodiesterase inhibitor that prevents cAMP degradation, thus potentially enhancing signaling pathways that activate Lipocalin-12 through elevated cAMP levels and subsequent PKA activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
This adrenergic agonist can stimulate cAMP production and activate PKA, which may affect downstream targets that modulate the functional activity of Lipocalin-12. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
A calcium channel agonist that can increase intracellular calcium levels, potentially leading to the activation of calcium-dependent signaling pathways that increase Lipocalin-12 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can activate PKA, leading to phosphorylation of downstream targets that could increase the functional activity of Lipocalin-12. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As an inhibitor of phosphodiesterase 4, Rolipram increases cAMP levels in cells, which could lead to PKA activation and subsequent modulation of pathways influencing Lipocalin-12 activity. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
An inhibitor of the Na+/K+-ATPase pump, which can lead to an increase in intracellular sodium and calcium concentrations, potentially activating signaling pathways that increase Lipocalin-12 activity. | ||||||